Zealand Pharma AS Performance
The firm maintains a market beta of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Zealand Pharma are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Zealand Pharma is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 960.2 M | |
| Total Cashflows From Investing Activities | -18.1 M |
Zealand |
Zealand Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Zealand Pharma AS on January 24, 2024 and sell it today you would earn a total of 100.00 from holding Zealand Pharma AS or generate -100.0% return on investment over 90 days. Zealand Pharma AS is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Zealand, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zealand Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zealand Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zealand Pharma AS, and traders can use it to determine the average amount a Zealand Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ZEAL |
Based on monthly moving average Zealand Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zealand Pharma by adding Zealand Pharma to a well-diversified portfolio.
Zealand Pharma Fundamentals Growth
Zealand Stock prices reflect investors' perceptions of the future prospects and financial health of Zealand Pharma, and Zealand Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zealand Stock performance.
| Return On Equity | -1.15 | |||
| Return On Asset | -0.38 | |||
| Operating Margin | (3.28) % | |||
| Current Valuation | 1.32 B | |||
| Shares Outstanding | 46.12 M | |||
| Price To Earning | 10.49 X | |||
| Price To Book | 9.54 X | |||
| Price To Sales | 2.77 X | |||
| Revenue | 292.57 M | |||
| EBITDA | (982.6 M) | |||
| Cash And Equivalents | 1.12 B | |||
| Cash Per Share | 25.99 X | |||
| Total Debt | 647.91 M | |||
| Debt To Equity | 1.11 % | |||
| Book Value Per Share | 10.91 X | |||
| Cash Flow From Operations | (1.21 B) | |||
| Earnings Per Share | (3.26) X | |||
| Total Asset | 2.07 B | |||
Things to note about Zealand Pharma AS performance evaluation
Checking the ongoing alerts about Zealand Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zealand Pharma AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zealand Pharma AS is not yet fully synchronised with the market data | |
| Zealand Pharma AS has some characteristics of a very speculative penny stock | |
| Zealand Pharma AS has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 292.57 M. Net Loss for the year was (1.02 B) with profit before overhead, payroll, taxes, and interest of 173.75 M. | |
| Zealand Pharma AS currently holds about 1.12 B in cash with (1.21 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.99. |
- Analyzing Zealand Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zealand Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Zealand Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zealand Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zealand Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zealand Pharma's stock. These opinions can provide insight into Zealand Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Zealand Pharma AS information on this page should be used as a complementary analysis to other Zealand Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Zealand Stock
If you are still planning to invest in Zealand Pharma AS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zealand Pharma's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |